LON:BVXP - Bioventix Stock Price, News, & Analysis

Sign in or create an account to add this stock to your watchlist.
GBX 3,599 +114.00 (+3.27 %)
(As of 02/22/2019 06:56 AM ET)
Previous CloseGBX 3,485
Today's RangeGBX 3,550 - GBX 3,599
52-Week RangeGBX 26.51 - GBX 2,950
Volume213 shs
Average Volume5,505 shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
Bioventix PLC manufactures and supplies sheep monoclonal antibodies (SMAs) for use in blood-testing machines in hospitals and other labs worldwide. The company offers a portfolio of purified SMAs for thyroid, vitamin D, cardiac, drugs of abuse, fertility, infectious disease, oncology, and miscellaneous indications. It also provides contract SMAs and recombinant services. The company was founded in 2003 and is based in London, the United Kingdom.

Receive BVXP News and Ratings via Email

Sign-up to receive the latest news and ratings for BVXP and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Biotechnology



Sales & Book Value

Annual SalesN/A



Next Earnings DateN/A
OptionableNot Optionable

Bioventix (LON:BVXP) Frequently Asked Questions

What is Bioventix's stock symbol?

Bioventix trades on the London Stock Exchange (LON) under the ticker symbol "BVXP."

How often does Bioventix pay dividends? What is the dividend yield for Bioventix?

Bioventix declared a dividend on Monday, October 8th. Investors of record on Thursday, October 25th will be given a dividend of GBX 91 per share on Friday, November 9th. This represents a dividend yield of 2.98%. The ex-dividend date is Thursday, October 25th. This is a boost from Bioventix's previous dividend of $25.00. The official announcement can be seen at this link. View Bioventix's Dividend History.

What price target have analysts set for BVXP?

0 brokerages have issued 1 year price targets for Bioventix's stock. Their predictions range from GBX 2,650 to GBX 2,650. On average, they anticipate Bioventix's stock price to reach GBX 2,650 in the next twelve months. This suggests that the stock has a possible downside of 26.4%. View Analyst Price Targets for Bioventix.

Has Bioventix been receiving favorable news coverage?

Press coverage about BVXP stock has been trending very negative this week, InfoTrie Sentiment Analysis reports. The research group scores the sentiment of media coverage by analyzing more than six thousand blog and news sources in real time. The firm ranks coverage of public companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Bioventix earned a media sentiment score of -3.0 on InfoTrie's scale. They also gave news headlines about the biotechnology company a news buzz of 6.0 out of 10, meaning that recent media coverage is somewhat likely to have an effect on the stock's share price in the near term.

Who are some of Bioventix's key competitors?

What other stocks do shareholders of Bioventix own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Bioventix investors own include Lancashire (LRE), Allena Pharmaceuticals (ALNA), GVC (GVC), Ampliphi Biosciences (APHB), Cerecor (CERC), AcelRx Pharmaceuticals (ACRX), Pieris Pharmaceuticals (PIRS), New York REIT (NYRT), MOTIF BIO PLC/S (MTFB) and NuCana (NCNA).

Who are Bioventix's key executives?

Bioventix's management team includes the folowing people:
  • Mr. Peter J. Harrison MA, CEO & Director (Age 61)
  • Ms. Treena Turner, Fin. Director & Director

How do I buy shares of Bioventix?

Shares of BVXP and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

What is Bioventix's stock price today?

One share of BVXP stock can currently be purchased for approximately GBX 3,599.

What is Bioventix's official website?

The official website for Bioventix is http://www.bioventix.com/.

How can I contact Bioventix?

Bioventix's mailing address is 7 Romans Business Park, East Street, FARNHAM, GU9 7SX, United Kingdom. The biotechnology company can be reached via phone at +44-1252-728001.

MarketBeat Community Rating for Bioventix (LON BVXP)

Community Ranking:  1.7 out of 5 (star)
Outperform Votes:  71 (Vote Outperform)
Underperform Votes:  141 (Vote Underperform)
Total Votes:  212
MarketBeat's community ratings are surveys of what our community members think about Bioventix and other stocks. Vote "Outperform" if you believe BVXP will outperform the S&P 500 over the long term. Vote "Underperform" if you believe BVXP will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 2/22/2019 by MarketBeat.com Staff

Featured Article: SEC Filing

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel